1,1,1-Trichloro-2,2,2-trifluoroethane
Common Name: |
1,1,1-Trichloro-2,2,2-trifluoroethane |
IUPAC Name: |
1,1,1-trichloro-2,2,2-trifluoroethane |
Molecular Formula: |
C2Cl3F3 |
SMILES: |
C(C(Cl)(Cl)Cl)(F)(F)F |
Inchi: |
1S/C2Cl3F3/c3-1(4,5)2(6,7)8 |
Inchi Key: |
BOSAWIQFTJIYIS-UHFFFAOYSA-N |
Cas No: |
354-58-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
3 |
Name |
Value |
Molecular Weight (g/mol) |
187.38 |
Mass (g/mol) |
185.902 |
Molar Refractivity |
26.35 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
1 |
Rings |
|
TPSA |
0.00 |
Hetero Atoms |
8 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
14.2 |
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
2.919 |
iLOGP |
1.77 |
XLOGP3 |
3.19 |
WLOGP |
4.18 |
MLOGP |
2.78 |
ESOL Log S |
-2.95 |
ESOL Solubility (mg/ml) |
0.212 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.86 |
Ali Solubility (mg/ml) |
0.26 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.67 |
Silicos-IT Solubility (mg/ml) |
0.41 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.18 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.102 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.123 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |